However, previous study reported that EGFR-TKI treatment increases the serum adiponectin levels in subjects with non-small cell lung cancer [26], but little is known about the molecular mechanism linking EGFR signaling or Mig-6 and adipokine secretion. This evidence concerns the gene ADIPOQ and non-small cell lung carcinoma.